CALABASAS, Calif., April 10, 2025 (GLOBE NEWSWIRE) — NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a clinical-stage biopharmaceutical company focused on innovative treatments for central nervous system (CNS) cancers and disorders, today announced that Executive Chairman Amir Heshmatpour has been appointed
CALABASAS, Calif., April 10, 2025 (GLOBE NEWSWIRE) — NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a clinical-stage biopharmaceutical company focused on innovative treatments for central nervous system (CNS) cancers and disorders, today announced that Executive Chairman Amir Heshmatpour has been appointed
CALABASAS, Calif., April 10, 2025 (GLOBE NEWSWIRE) — NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a clinical-stage biopharmaceutical company focused on innovative treatments for central nervous system (CNS) cancers and disorders, today announced that Executive Chairman Amir Heshmatpour has been appointed
CALABASAS, Calif., April 10, 2025 (GLOBE NEWSWIRE) — NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a clinical-stage biopharmaceutical company focused on innovative treatments for central nervous system (CNS) cancers and disorders, today announced that Executive Chairman Amir Heshmatpour has been appointed
Sougwen Chung, ‘SPECTRAL – Oscillation 1’, 2024, Acrylic on Perspex, Created with D.O.U.G._5 Bespoke Robotic System, 152.5 x 152 cm (Image courtesy of Phillips & HOFA) Sougwen Chung, ‘SPECTRAL – Oscillation 1’, 2024, Acrylic on Perspex, Created with D.O.U.G._5 Bespoke
Sougwen Chung, ‘SPECTRAL – Oscillation 1’, 2024, Acrylic on Perspex, Created with D.O.U.G._5 Bespoke Robotic System, 152.5 x 152 cm (Image courtesy of Phillips & HOFA) Sougwen Chung, ‘SPECTRAL – Oscillation 1’, 2024, Acrylic on Perspex, Created with D.O.U.G._5 Bespoke